Details for New Drug Application (NDA): 050619
✉ Email this page to a colleague
NDA 050619 describes MYCOSTATIN, which is a drug marketed by Delcor Asset Corp and is included in seven NDAs. Additional details are available on the MYCOSTATIN profile page.
The generic ingredient in MYCOSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in MYCOSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 050619
| Tradename: | MYCOSTATIN |
| Applicant: | Delcor Asset Corp |
| Ingredient: | nystatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050619
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | PASTILLE;ORAL | Strength | 200,000 UNITS | ||||
| Approval Date: | Apr 9, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
